Anila Lingamneni's Insider Trades & SAST Disclosures
Anila Lingamneni's most recent trade in Haemonetics Corp. was a trade of 2,136 Common Stock done at an average price of $90 . Disclosure was reported to the exchange on July 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anila Lingamneni.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Jul 2024 | 2,136 | 21,410 (0%) | 0% | 90 | 192,240 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Jul 2024 | 79 | 21,331 (0%) | 0% | 90 | 7,110 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 14,140 | 28,825 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.73 per share. | 28 May 2024 | 5,279 | 23,546 (0%) | 0% | 95.7 | 505,359 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 7,461 | 7,461 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 3,394 | 14,685 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.73 per share. | 17 May 2024 | 349 | 11,291 (0%) | 0% | 95.7 | 33,410 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.49 per share. | 15 May 2024 | 337 | 11,958 (0%) | 0% | 96.5 | 32,517 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.80 per share. | 15 May 2024 | 318 | 11,640 (0%) | 0% | 94.8 | 30,146 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 06 May 2024 | 2,305 | 12,295 (0%) | 0% | 95 | 218,975 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.88 per share. | 15 Apr 2024 | 184 | 14,311 (0%) | 0% | 84.9 | 15,618 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Sep 2023 | 2,305 | 14,495 (0%) | 0% | 90 | 207,450 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 83.33 per share. | 30 May 2023 | 2,304 | 16,800 (0%) | 0% | 83.3 | 191,992 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 18 May 2023 | 1,385 | 19,104 (0%) | 0% | 83.3 | 115,426 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 7,602 | 7,602 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 3,364 | 20,807 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.21 per share. | 15 May 2023 | 318 | 20,489 (0%) | 0% | 89.2 | 28,369 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.78 per share. | 14 Apr 2023 | 176 | 17,146 (0%) | 0% | 84.8 | 14,921 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 59.10 per share. | 19 May 2022 | 1,384 | 17,322 (0%) | 0% | 59.1 | 81,794 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 10,148 | 10,148 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 4,340 | 18,706 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 56.55 per share. | 18 Apr 2022 | 189 | 14,013 (0%) | 0% | 56.6 | 10,688 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 9,564 | 9,564 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 7,070 | 14,294 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 3,535 | 7,224 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 55.18 per share. | 18 May 2021 | 92 | 14,202 (0%) | 0% | 55.2 | 5,077 | Common Stock |
| Haemonetics Corp. | Anila Lingamneni | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 119.44 per share. | 16 Apr 2021 | 170 | 3,444 (0%) | 0% | 119.4 | 20,305 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges